You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acalabrutinib

Showing 101 - 125 of 137
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib, Venetoclax, Chemoimmunotherapy)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Acalabrutinib
  • +3 more
  • Fountain Valley, California
  • +201 more
Jan 16, 2023

NHL, DLBCL, Non-hodgkin's Lymphoma Trial in United Kingdom, United States (AZD9150, Acalabrutinib, AZD6738)

Completed
  • NHL
  • +3 more
  • Los Angeles, California
  • +11 more
Aug 11, 2022

Healthy Participants Trial in Tempe (ACP-196, Itraconazole)

Completed
  • Healthy Participants
  • Tempe, Arizona
    Celerion
May 20, 2021

Healthy Participants Trial in Tempe (ACP-196, Calcium carbonate, Omeprazole)

Completed
  • Healthy Participants
  • Tempe, Arizona
    (unnamed)
May 31, 2021

Healthy Volunteers Trial in Tempe (ACP-196, Moxifloxacin 400 mg, Placebo)

Completed
  • Healthy Volunteers
  • Tempe, Arizona
    Celerion
Apr 28, 2021

Hepatic Insufficiency Trial in Miami, Orlando, Knoxville (ACP-196)

Completed
  • Hepatic Insufficiency
  • Miami, Florida
  • +2 more
Apr 28, 2021

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Acalabrutinib
  • Chandler, Arizona
  • +107 more
Mar 8, 2022

Multiple Myeloma (MM) Trial in Baltimore, Leicester, London (acalabrutinib)

Completed
Has Results
  • Multiple Myeloma (MM)
  • acalabrutinib
  • Baltimore, Maryland
  • +2 more
Jul 15, 2020

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib (ACP-196), Rituximab, Idelalisib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Acalabrutinib (ACP-196)
  • +3 more
  • Chandler, Arizona
  • +156 more
Jun 2, 2022

Lymphoma, Mantle Cell Trial in Worldwide (Acalabrutinib, Bendamustine, Rituximab)

Recruiting
  • Lymphoma, Mantle Cell
  • Acalabrutinib
  • +3 more
  • Downey, California
  • +231 more
Jan 16, 2023

Covid19 Trial in Philippines (Remdesivir, Hydroxychloroquine, Lopinavir / Ritonavir)

Completed
  • Covid19
  • Baguio City, Benguet, Philippines
  • +24 more
Feb 27, 2022

Advanced Haematological Malignancies Trial in Worldwide (AZD4573, Acalabrutinib)

Recruiting
  • Advanced Haematological Malignancies
  • Duarte, California
  • +38 more
Jul 22, 2022

Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance

Not yet recruiting
  • Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
    • (no location specified)
    Dec 16, 2022

    Atrial Fibrillation Trial in Caen (Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®))

    Not yet recruiting
    • Atrial Fibrillation
    • Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®)
    • Caen, Normandie, France
      Caen University Hospital, Department of Pharmacology
    Sep 6, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (IOV-2001, Low dose IL-2, High dose IL-2)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • IOV-2001
    • +3 more
    • Tampa, Florida
    • +5 more
    Jan 31, 2022

    Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance

    Active, not recruiting
    • Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
      • Aichi, Japan
      • +48 more
      Dec 7, 2022

      Non-hodgkin Lymphoma,B Cell Trial in Seoul (Acalabrutinib)

      Unknown status
      • Non-hodgkin Lymphoma,B Cell
      • Acalabrutinib
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Sep 17, 2019

      CLL/SLL Trial (lisaftoclax +BTK inhibitor, BTK inhibitor)

      Not yet recruiting
      • CLL/SLL
      • lisaftoclax +BTK inhibitor
      • BTK inhibitor
      • (no location specified)
      Oct 26, 2023

      Hepatitis, Safety and Tolerability Trial run by the NHLBI (HEPLISAV-B)

      Completed
      Has Results
      • Hepatitis
      • Safety and Tolerability
      • HEPLISAV-B
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 13, 2022

      NSCLC Trial in Goodyear (Pembrolizumab, Acalabrutinib)

      Completed
      Has Results
      • Carcinoma, Non-Small-Cell Lung
      • Goodyear, Arizona
        Western Regional Medical Center/Cancer Treatment Center of Ameri
      Aug 22, 2019

      Warm Autoimmune Hemolytic Anemia Trial in Beijing (Zanubrutinib)

      Not yet recruiting
      • Warm Autoimmune Hemolytic Anemia
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Jun 20, 2023

      Safety and Tolerability, Compare SHINGRIX Vaccine Response Rates, Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI

      Active, not recruiting
      Has Results
      • Safety and Tolerability
      • +3 more
      • Zoster Vaccine Recombinant, Adjuvanted
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 10, 2022

      Lymphoma, Mantle-Cell Trial in Worldwide (Pirtobrutinib, Ibrutinib, Acalabrutinib)

      Recruiting
      • Lymphoma, Mantle-Cell
      • Phoenix, Arizona
      • +158 more
      Aug 15, 2022

      Richter Syndrome Trial (Acalabrutinib, Cyclophosphamide, Doxorubicin)

      Not yet recruiting
      • Richter Syndrome
      • Acalabrutinib
      • +5 more
      • (no location specified)
      Mar 31, 2019

      Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest Trial in New Hyde Park (Medtronic

      Recruiting
      • Atrial Fibrillation
      • +4 more
      • Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
      • New Hyde Park, New York
        Northwell (Northshore University/Long Island Jewish Hospitals)
      Dec 1, 2022